Nymox Pharmaceutical Corporation announced effective June 28, 2022, accepted the resignation of Erik Danielsen as Chief Financial Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2299 USD | +55.34% |
|
+155.44% | -61.03% |
1st Jan change | Capi. | |
---|---|---|
-61.03% | 21.46M | |
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+35.57% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |
- Stock Market
- Equities
- NYMXF Stock
- News Nymox Pharmaceutical Corporation
- Nymox Pharmaceutical Corporation Announces Resignation of Erik Danielsen as Chief Financial Officer